Acetylation of Checkpoint Suppressor 1 Enhances Its Stability and Promotes the Progression of Triple-Negative Breast Cancer

Researchers found that checkpoint suppressor 1 had a high abundance in TNBC and its expression was tightly associated with malignant phenotype and poor outcomes of patients.